Abstract

Neutrophils are the body’s primary responders to infection and injury, yet they also exert diverse effects within tumours through distinct subtypes and mechanisms of action. In light of persistent challenges in clinical oncology, including drug resistance, a research focus on neutrophil biology represents a promising frontier. This review examines neutrophil heterogeneity in cancer by exploring their developmental stages, tumour-specific mechanisms influencing progression, and established classification systems. It further highlights emerging neutrophil subpopulations identified across specific tumours and disease contexts, offering insights into their dual roles in pathogenesis. By integrating recent findings, this work provides a framework to guide drug development and clinical therapeutics in oncology and related pathologies.

Affiliated Institutions

Related Publications

Publication Info

Year
2025
Type
article
Volume
16
Citations
0
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

0
OpenAlex

Cite This

Hua Lin, Yutian Liao, Zhonghui Chen et al. (2025). Mechanistic roles of neutrophil heterogeneity in tumour pathogenesis. Frontiers in Immunology , 16 . https://doi.org/10.3389/fimmu.2025.1721090

Identifiers

DOI
10.3389/fimmu.2025.1721090